Last reviewed · How we verify
NCT04951765
A Phase I Study to Examine the Effects of Low and High-fat Meals on Orally Administered XZP-3287 in Healthy Adult Subjects
Phase 1 trial testing XZP-3287 in Healthy in 24 participants. Status unknown.
1 August 2021
Quick facts
| Lead sponsor | Xuanzhu Biopharmaceutical Co., Ltd. |
|---|---|
| Phase | Phase 1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 August 2021 |
| Primary completion | 1 August 2021 |
| Estimated completion | 1 December 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- XZP-3287 — full drug profile →
- XZP-3287 — full drug profile →
- XZP-3287 — full drug profile →
- XZP-3287 — full drug profile →
- XZP-3287 — full drug profile →
- XZP-3287 — full drug profile →
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Xuanzhu Biopharmaceutical Co., Ltd. — full company profile →
Who can join
Adults 18 to 65, any sex, with Healthy. Healthy volunteers can join.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Primary PK Endpoints
Time frame: day 1~day 21
Cmax -
Primary PK Endpoints
Time frame: day 1~day 21
AUC0-∞ -
Primary PK Endpoints
Time frame: day 1~day 21
AUC0-t
Sponsor's own description
This study will be a randomized 3-treatment, cross-over study to evaluate the bioavailability of XZP-3287 administered after a high or low-fat meal.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04951765
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of XZP-3287
Trials testing the same drug.
- NCT04539496 — A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors · Phase 1, PHASE2 · active not recruiting
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Xuanzhu Biopharmaceutical Co., Ltd. trials
Trials by the same sponsor.
- NCT07345689 — A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations · Phase 4 · not yet recruiting
- NCT07330531 — Drug-drug Interaction Study of Rifampin and Anaprazole Sodium · Phase 4 · not yet recruiting
- NCT05586568 — Drug-drug Interaction Study of XZP-3621 Tablet · Phase 1 · unknown
- NCT05478109 — A Clinical Trial of XZP-3287 for Material Balance · Phase 1 · unknown
- NCT05257395 — A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04951765 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xuanzhu Biopharmaceutical Co., Ltd.
- Last refreshed: 20 July 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04951765.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing